These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30063648)

  • 21. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses.
    Amelio P; Portevin D; Hella J; Reither K; Kamwela L; Lweno O; Tumbo A; Geoffrey L; Ohmiti K; Ding S; Pantaleo G; Daubenberger C; Perreau M
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of Mortality among Tuberculosis/HIV-Coinfected Persons in Southwest Ethiopia: A Case-Control Study.
    Deribe K; Yami A; Deribew A; Mesfin N; Colebunders R; Van Geertruyden JP; Woldie M; Maja T
    J Int Assoc Provid AIDS Care; 2015; 14(3):269-73. PubMed ID: 23966102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
    Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
    Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
    Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
    AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study.
    Sekaggya-Wiltshire C; Castelnuovo B; von Braun A; Musaazi J; Muller D; Buzibye A; Gutteck U; Henning L; Ledergerber B; Corti N; Lamorde M; Fehr J; Kambugu A
    BMJ Open; 2017 Sep; 7(9):e014679. PubMed ID: 28928173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
    Tshitenge S; Ogunbanjo GA; Citeya A
    Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis Exacerbates HIV-1 Infection through IL-10/STAT3-Dependent Tunneling Nanotube Formation in Macrophages.
    Souriant S; Balboa L; Dupont M; Pingris K; Kviatcovsky D; Cougoule C; Lastrucci C; Bah A; Gasser R; Poincloux R; Raynaud-Messina B; Al Saati T; Inwentarz S; Poggi S; Moraña EJ; González-Montaner P; Corti M; Lagane B; Vergne I; Allers C; Kaushal D; Kuroda MJ; Sasiain MDC; Neyrolles O; Maridonneau-Parini I; Lugo-Villarino G; Vérollet C
    Cell Rep; 2019 Mar; 26(13):3586-3599.e7. PubMed ID: 30917314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection by HTLV-1 Is Associated With High Levels of Proinflammatory Cytokines in HIV-HCV-Coinfected Patients.
    Brites C; Abrahão M; Bozza P; Netto EM; Lyra A; Bahia F
    J Acquir Immune Defic Syndr; 2018 Feb; 77(2):230-234. PubMed ID: 29084047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients.
    Wolday D; Tegbaru B; Kassu A; Messele T; Coutinho R; van Baarle D; Miedema F
    J Acquir Immune Defic Syndr; 2005 Jul; 39(3):265-71. PubMed ID: 15980685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus.
    Petrara MR; Cattelan AM; Sasset L; Freguja R; Carmona F; Sanavia S; Zanchetta M; Del Bianco P; De Rossi A
    PLoS One; 2017; 12(9):e0185128. PubMed ID: 28926641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.
    Conesa-Botella A; Loembé MM; Manabe YC; Worodria W; Mazakpwe D; Luzinda K; Mayanja-Kizza H; Miri M; Mbabazi O; Koole O; Kestens L; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Dec; 58(5):463-8. PubMed ID: 21963941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.
    Mahan CS; Walusimbi M; Johnson DF; Lancioni C; Charlebois E; Baseke J; Chervenak KA; Mugerwa RD; Havlir DV; Mayanja-Kizza H; Whalen CC; Boom WH;
    PLoS One; 2010 Feb; 5(2):e9138. PubMed ID: 20179751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
    López-Cortés LF; Trujillo-Rodríguez M; Báez-Palomo A; Benmarzouk-Hidalgo OJ; Dominguez-Molina B; Milanés-Guisado Y; Espinosa N; Viciana P; Gutiérrez-Valencia A
    J Infect Dis; 2018 Jul; 218(4):624-632. PubMed ID: 29986086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the NK Cell Repertoire Related to Initiation of TB Treatment and Onset of Immune Reconstitution Inflammatory Syndrome in TB/HIV Co-infected Patients in Rio de Janeiro, Brazil-ANRS 12274.
    Giacoia-Gripp CBW; Cazote ADS; da Silva TP; Sant'Anna FM; Schmaltz CAS; Brum TS; de Matos JA; Silva J; Benjamin A; Pilotto JH; Rolla VC; Morgado MG; Scott-Algara D
    Front Immunol; 2019; 10():1800. PubMed ID: 31456797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection.
    Freeman ML; Mudd JC; Shive CL; Younes SA; Panigrahi S; Sieg SF; Lee SA; Hunt PW; Calabrese LH; Gianella S; Rodriguez B; Lederman MM
    Clin Infect Dis; 2016 Feb; 62(3):392-6. PubMed ID: 26400999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.
    Wejse C; Furtado A; Camara C; Lüneborg-Nielsen M; Sodemann M; Gerstoft J; Katzenstein TL
    Int J Infect Dis; 2013 Oct; 17(10):e907-12. PubMed ID: 23816410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatment.
    Ku NS; Oh JO; Shin SY; Kim SB; Kim HW; Jeong SJ; Han SH; Song YG; Kim JM; Choi JY
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):226-30. PubMed ID: 22881387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-γ-Inducible Protein 10 (IP-10) Kinetics after Antiretroviral Treatment Initiation in Ethiopian Adults with HIV.
    Thorman J; Björkman P; Marrone G; Tolera Balcha T; Tesfaye F; Abdissa T; Naniche D; Medstrand P; Reepalu A
    Microbiol Spectr; 2021 Dec; 9(3):e0181021. PubMed ID: 34908450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.
    Tan HY; Yong YK; Andrade BB; Shankar EM; Ponnampalavanar S; Omar SF; Narendran G; Kamarulzaman A; Swaminathan S; Sereti I; Crowe SM; French MA
    AIDS; 2015 Feb; 29(4):421-31. PubMed ID: 25565499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.